Nerve-sparing surgery preserves the neurovascular bundles responsible for erection. Whether it is oncologically safe depends on where the cancer is located — not just whether the surgeon is willing to do it.
When a urologist talks about "nerve-sparing prostatectomy," they are referring to the preservation of the neurovascular bundles — paired structures that run on either side of the prostate and carry the nerves responsible for producing erections. Understanding what nerve-sparing means, whether you qualify, and what realistic outcomes look like is essential for informed decision-making.
1. The neurovascular bundles — anatomy and function
The neurovascular bundles (NVBs) are paired structures that run posterolaterally along the prostate — one on each side. They contain the cavernous nerves, which are responsible for triggering the smooth muscle relaxation in the penis that produces an erection in response to sexual stimulation.
These nerves are microscopic — they cannot be seen by the naked eye. They are identified by their anatomical location relative to the prostate capsule and surrounding tissue. During prostatectomy, the surgeon must decide how close to dissect to the prostate surface — close enough to remove all cancer, but far enough to preserve these nerve fibres.
The cavernous nerves are extremely delicate. Once stretched, compressed, or divided, they cannot be repaired. If the NVB must be excised to achieve cancer-free margins, erectile function on that side will not recover — regardless of any subsequent treatment.
2. Who qualifies for nerve-sparing?
Nerve-sparing is safe only when the cancer is not immediately adjacent to, or involving, the neurovascular bundle. The key factors that determine eligibility are:
- Cancer location on biopsy: If cancer is found predominantly on the left side posteriorly, the right NVB can typically be spared safely — and vice versa.
- MRI findings: mpMRI showing tumour abutting or invading the NVB is a contraindication to nerve-sparing on that side.
- Gleason grade: High-grade (GG4–5, Gleason 8–10) tumours are more likely to have extraprostatic extension, making nerve-sparing riskier.
- PSA density and clinical stage: T3 disease (extending beyond the prostate capsule) on MRI generally contraindicates nerve-sparing on the involved side.
- Preoperative erectile function: Nerve-sparing is most worthwhile in men who have good baseline erectile function. In men with severely impaired preoperative function, the benefit of nerve preservation is limited.
Nerve-sparing must never compromise cancer removal. A surgeon who spares nerves despite tumour involvement to improve functional outcomes is prioritising the wrong outcome. Clear surgical margins are the primary goal — nerve preservation is secondary to complete cancer excision.
3. Bilateral versus unilateral nerve-sparing
- One NVB excised with the prostate
- Other NVB fully preserved
- Erection recovery possible but less robust
- Appropriate when cancer is asymmetric
- Better cancer control on involved side
- Both NVBs preserved
- Best prospects for erectile recovery
- Requires low-risk, small-volume, central tumour
- Lower PSA and Gleason typically required
- Ongoing intraoperative judgement by surgeon
4. How nerve-sparing is performed robotically
The robotic platform provides a critical advantage for nerve-sparing surgery: 3D magnification up to 10x, and articulating instruments that allow dissection in millimetre increments along the prostate surface.
The technique involves one of two approaches:
Interfascial nerve-sparing (close to the prostate)
The dissection plane follows immediately alongside the prostate capsule, within the periprostatic fascial layers. This maximally preserves the NVB but carries a slightly higher risk of a positive margin if the cancer is capsular. This approach is used for low-risk, confined disease.
Intrafascial nerve-sparing (inside the prostatic fascia)
An even more nerve-preserving technique — the dissection plane runs within the periprostatic fascia, preserving more neural tissue around the NVB. Reserved for very low-risk, small-volume, anterior tumours with no posterior involvement.
The final nerve-sparing decision is made during surgery, not before it. The surgeon may find that the tissue planes are not safe to preserve — perhaps a small capsular penetration is found during dissection. An experienced surgeon will convert to wider excision rather than compromise cancer control. This is why discussing intraoperative decision-making with your surgeon beforehand is important.
5. Realistic outcomes for erectile function
Nerve-sparing surgery does not immediately restore erectile function — the cavernous nerves are traumatised by the dissection (stretched, compressed, heated by instruments) even when not divided. Recovery is a process of nerve regeneration that takes time.
6. Penile rehabilitation after nerve-sparing
Penile rehabilitation — active treatment to promote erectile recovery — should begin 4–6 weeks after surgery. The rationale is that regular oxygenation of the erectile tissue (corpus cavernosum) prevents fibrosis and maintains the structural architecture of the penis during the recovery period.
Daily PDE5 inhibitor (tadalafil or sildenafil)
Low-dose daily tadalafil (5 mg) or regular sildenafil promotes nocturnal erections and tissue oxygenation. Even without a full erection, this has a rehabilitative effect on cavernous smooth muscle.
Vacuum erection device (VED)
A vacuum device mechanically produces an erection by drawing blood into the penis. Used regularly — 10 minutes daily from 6 weeks post-op — it helps maintain penile length and promotes tissue oxygenation.
Combination therapy
For patients with slower recovery, intracavernosal injections (alprostadil, directly into the corpus cavernosum) produce reliable erections regardless of nerve status and can be used while awaiting spontaneous recovery.
- Is nerve-sparing safe in my case — based on MRI, biopsy location, and grade?
- Will you spare one side or both — and what determines that decision?
- What is your nerve-sparing rate and your erectile function recovery rate at your centre?
- What rehabilitation will you recommend after surgery?
- What happens if you find involvement during surgery — will you discuss with me before wider excision?
- Am I a candidate for penile injections if standard rehabilitation does not work?
This article is for general patient education only. Nerve-sparing eligibility and outcomes vary significantly based on individual cancer characteristics and surgeon experience. Discuss your specific situation in detail with your urologist.